Search Results - Lanschot, Joseph Jan‐Baptist

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance

    Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance by Graham Martinez, Cristina, Kus Öztürk, Sonay, Al‐Kaabi, Ali, Valkema, Maria J, Bokhorst, John‐Melle, Rosman, Camiel, Rütten, Heidi, Wauters, Carla A P, Doukas, Michail, Lanschot, Joseph Jan‐Baptist, Siersema, Peter D, Nagtegaal, Iris D, Post, Rachel Sofia

    Published in Histopathology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    ASO Author Reflections: Opting for a Cost-Effective Treatment Allocation in Patients with Esophageal Cancer

    ASO Author Reflections: Opting for a Cost-Effective Treatment Allocation in Patients with Esophageal Cancer by Gao, Xing, van Lanschot, Joseph Jan-Baptist, Chao, Yin-Kai

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma—A Cost-Effectiveness Analysis

    ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma—A Cost-Effectiveness Analysis by Gao, Xing, Wen, Yu-Wen, van Lanschot, Joseph Jan Baptist, Chao, Yin-Kai

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis

    Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis by Gao, Xing, Wen, Yu-Wen, van Lanschot, Joseph Jan Baptist, Chao, Yin-Kai

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study

    Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study by Gao, Xing, Yang, Zhi-Hao, Cheng, Yi-Hsuan, Chi, Chun-Ling, Yang, Tzu-Yi, Chuang, Kai-Hao, Wu, Chiao-En, van Lanschot, Joseph Jan-Baptist, Wen, Yu-Wen, Chao, Yin-Kai

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study

    Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparati... by Gao, Xing, Tsai, Ping-Chung, Chuang, Kai-Hao, Pai, Chu-Pin, Hsu, Po-Kuei, Li, Shau-Hsuan, Lu, Hung-I, van Lanschot, Joseph Jan-Baptist, Chao, Yin-Kai

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    377. NEOADJUVANT CARBOPLATIN/PACLITAXEL VERSUS 5-FLUOROURACIL/CISPLATIN IN COMBINATION WITH RADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A MULTICENTER COMPARATIVE STUDY

    377. NEOADJUVANT CARBOPLATIN/PACLITAXEL VERSUS 5-FLUOROURACIL/CISPLATIN IN COMBINATION WITH RADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A MULTICENTER COMPARATIVE STUDY by Gao, Xing, Tsai, PingChung, Chuang, KaiHao, Pai, ChuPin, Hsu, PoKuei, Lee, ShauHsuan, Lu, HungI, van Lanschot, Joseph Jan-Baptist, Chao, YinKai

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: